<DOC>
	<DOCNO>NCT00108563</DOCNO>
	<brief_summary>The purpose study learn effect interferon ribavirin combination therapy people Hepatitis C. The specific aim : - To assess often depressive symptom occur patient take combination alpha interferon plus ribavirin pegylated interferon plus ribavirin therapy Hepatitis C , depressive symptom occur , severe depressive symptom occur ; - To identify potential predictor development depressive symptom ; - To identify citalopram , antidepressant medication , prevent lessen severity depressive symptom bring interferon therapy .</brief_summary>
	<brief_title>VISN 20 : Prophylactic Treatment Interferon-Induced Depression Hepatitis C Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Adult male female , age 18 old Planning receive brand pegylated interferon/ribavirin combination therapy chronic HCV ( hepatitis C virus ) Chronic liver disease chronic HCV Evidence advance liver disease history presence ascites , bleed varix , spontaneous encephalopathy A history organ transplantation Any known preexisting medical condition could interfere patient 's participation protocol , include : *active seizure disorder require medication ; *history major CNS ( central nervous system ) trauma ( suggested accident event lead loss consciousness , personality change , etc ) Any medical condition requiring , likely require course study , chronic systemic administration steroid ( e.g . oral injection ) . Inability read write level sufficient complete selfreport form History significant noncompliance medical treatment appointment Patients currently , within last three month , full therapeutic dose antidepressant medication , dose medication may significantly affect depressive symptomatology Patients active depression previous 3 month and/or BDI ( Beck Depression Inventory ) II great equal 15 time study entry . Patients bipolar disorder history bipolar disorder Patients active psychotic symptom diagnosis schizophrenia previous 3 month Active substance abuse , alcohol ( great 80 gm/day ) , IV ( intravenous ) drug , inhale drug . If patient history substance abuse , order consider inclusion protocol , patient must sustain remission least 6 month Patients receive opiate agonist therapy ( e.g. , methadone maintenance therapy ) within past year , unless program test continue substance abuse initiate ( test entry randomly least every 23 month ) patient withdrawn study violation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Depression</keyword>
	<keyword>Interferon-alpha</keyword>
	<keyword>Citalopram</keyword>
	<keyword>ribavirin</keyword>
	<keyword>antidepressive agent</keyword>
</DOC>